Group One Trading
KITE

Group One Trading’s Kite Pharma, Inc. KITE Stock Holding History

Group One Trading’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-352,500
Closed -$63.4M – 5611
2017
Q3 		$63.4M Buy
352,500
+271,200
+334% +$37.8M 0.58% 8
2017
Q2 		$8.43M Buy
81,300
+37,600
+86% +$3.07M 0.09% 261
2017
Q1 		$3.43M Buy
43,700
+36,500
+507% +$2.26M 0.04% 568
2016
Q4 		$323K Sell
7,200
-80,800
-92% -$3.96M ﹤0.01% 2074
2016
Q3 		$4.92M Buy
88,000
+56,800
+182% +$3.16M 0.05% 423
2016
Q2 		$1.56M Buy
31,200
+28,000
+875% +$1.38M 0.02% 958
2016
Q1 		$147K Sell
3,200
-17,300
-84% -$838K ﹤0.01% 2540
2015
Q4 		$1.26M Buy
20,500
+10,100
+97% +$711K 0.01% 1152
2015
Q3 		$579K Sell
10,400
-44,300
-81% -$2.79M 0.01% 1654
2015
Q2 		$3.33M Sell
54,700
-2,000
-4% -$114K 0.05% 480
2015
Q1 		$3.27M Buy
56,700
+55,900
+6,988% +$3.75M 0.05% 411
2014
Q4 		$46K Buy
+800
New +$33.7K ﹤0.01% 3430

Group One Trading's KITE Position: Q3 2017 in Review

Group One Trading sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 32,877 shares — an estimated $4.58M sold.

Group One Trading first reported a position in KITE in Q4 2014 and held it in 7 quarters. The position peaked at $3.41M in Q2 2017. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

  • Group One Trading reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • Group One Trading sold 32,877 Kite Pharma, Inc. shares in Q3 2017, an estimated $4.58M.
  • Group One Trading first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 7 quarters.
  • Group One Trading's Kite Pharma, Inc. position peaked at $3.41M in Q2 2017.
  • 244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Group One Trading's 13F filing for Q3 2017, filed 15 Nov 2017.